Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Psychemedics Corporation is a diagnostics & research business based in the US. Psychemedics Corporation shares (PMD) are listed on the NASDAQ and all prices are listed in US Dollars. Psychemedics Corporation employs 204 staff and has a trailing 12-month revenue of around USD$24.7 million.
|Latest market close||USD$4.88|
|52-week range||USD$3.58 - USD$10.4797|
|50-day moving average||USD$4.1424|
|200-day moving average||USD$4.7933|
|Wall St. target price||USD$32|
|Dividend yield||USD$0.72 (13.74%)|
|Earnings per share (TTM)||USD$0.137|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-08)||-8.61%|
|1 month (2020-12-16)||3.61%|
|3 months (2020-10-15)||14.82%|
|6 months (2020-07-15)||-6.33%|
|1 year (2020-01-15)||-51.97%|
|2 years (2019-01-15)||-72.83%|
|3 years (2018-01-15)||N/A|
|5 years (2016-01-15)||9.01|
Valuing Psychemedics Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Psychemedics Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Psychemedics Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 37x. In other words, Psychemedics Corporation shares trade at around 37x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Psychemedics Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$224,000.
The EBITDA is a measure of a Psychemedics Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$24.7 million|
|Gross profit TTM||USD$16.4 million|
|Return on assets TTM||-11.73%|
|Return on equity TTM||-24.84%|
|Market capitalisation||USD$28.2 million|
TTM: trailing 12 months
There are currently 5,289 Psychemedics Corporation shares held short by investors – that's known as Psychemedics Corporation's "short interest". This figure is 21.3% down from 6,722 last month.
There are a few different ways that this level of interest in shorting Psychemedics Corporation shares can be evaluated.
Psychemedics Corporation's "short interest ratio" (SIR) is the quantity of Psychemedics Corporation shares currently shorted divided by the average quantity of Psychemedics Corporation shares traded daily (recently around 22995.652173913). Psychemedics Corporation's SIR currently stands at 0.23. In other words for every 100,000 Psychemedics Corporation shares traded daily on the market, roughly 230 shares are currently held short.
However Psychemedics Corporation's short interest can also be evaluated against the total number of Psychemedics Corporation shares, or, against the total number of tradable Psychemedics Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Psychemedics Corporation's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Psychemedics Corporation shares in existence, roughly 0 shares are currently held short) or 0.001% of the tradable shares (for every 100,000 tradable Psychemedics Corporation shares, roughly 1 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Psychemedics Corporation.
Find out more about how you can short Psychemedics Corporation stock.
We're not expecting Psychemedics Corporation to pay a dividend over the next 12 months.
Psychemedics Corporation's shares were split on a 1:4 basis on 1 August 2002. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Psychemedics Corporation shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Psychemedics Corporation shares which in turn could have impacted Psychemedics Corporation's share price.
Over the last 12 months, Psychemedics Corporation's shares have ranged in value from as little as $3.58 up to $10.4797. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Psychemedics Corporation's is 0.8619. This would suggest that Psychemedics Corporation's shares are less volatile than average (for this exchange).
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, amphetamines, opiates, synthetic cannabinoids, and benzodiazepines. Its testing results provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data that can show a pattern of individual drug use over a longer period-of-time. The company provides its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was founded in 1986 and is headquartered in Acton, Massachusetts.
Everything we know about the Vacasa IPO, plus information on how to buy in.
Everything we know about the William Penn Bancorp IPO, plus information on how to buy in.
Everything we know about the Landos Biopharma Inc IPO, plus information on how to buy in.
Everything we know about the First High-School Education Group Co Ltd IPO, plus information on how to buy in.
Everything we know about the Knowlton Development Corp IPO, plus information on how to buy in.
Steps to owning and managing SASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing SAIL, with 24-hour and historical pricing before you buy.
Steps to owning and managing SAF, with 24-hour and historical pricing before you buy.
Steps to owning and managing RDHL, with 24-hour and historical pricing before you buy.
Steps to owning and managing SBFG, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.